Encare

Manufacturer: Blairex Laboratories, Inc.
Effective date: 2013-09-03
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: legacy-cache
Hydrated at: 2026-08-01 23:56:09

Label at a glance#

ProductEncare

Active ingredientnonoxynol-9

Label structure12 sections

Dosage and administration

at least 10 minutes prior to intercourse : remove the protective wrap and insert Encare into the vagina (see diagram on package insert). Each Encare insert gives you one full hour of protection. may be used with: condom or diaphragm for added protection. before use: read all directions and special warnings on this package and the insert inside.

Contacts and useful links#

PhoneLabel contact1-800-252-4739

Websitewww.encare.net

www.encare.net

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient (in each insert)

OTC - ACTIVE INGREDIENT SECTION

Nonoxynol-9 100 mg.

Purpose

OTC - PURPOSE SECTION

Vaginal Contraceptive

Use

INDICATIONS & USAGE SECTION

for the prevention of pregnancy.

Warnings

WARNINGS SECTION

For vaginal use only
Not for rectal (anal) use

SPL UNCLASSIFIED SECTION

Sexually transmitted diseases (STDs) alert: This product does not protect against HIV/AIDS or other STDs and may increase the risk of getting HIV from an infected partner.

Do not use if you or your sex partner has HIV/AIDS. If you do not know if you or your sex partner is infected, choose another form of birth control.

When using this product

OTC - WHEN USING SECTION

you may get vaginal irritation (burning, itching, or a rash)

Stop use and ask a doctor if

OTC - STOP USE SECTION

you or your partner get burning, itching, a rash or other irritation of the vagina or penis

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

at least 10 minutes prior to intercourse: remove the protective wrap and insert Encare into the vagina (see diagram on package insert). Each Encare insert gives you one full hour of protection.
may be used with: condom or diaphragm for added protection.
before use: read all directions and special warnings on this package and the insert inside.

Other information

SPL UNCLASSIFIED SECTION

when used correctly every time you have sex, latex condoms greatly reduce, but do not eliminate, the risk of catching or spreading HIV, the virus that causes AIDS
store at 15-30°C (59-86°F)
keep away from excessive heat and moisture.

Inactive ingredients

INACTIVE INGREDIENT SECTION

polyethylene glycols, sodium bicarbonate, sodium citrate, tartaric acid.

Manufactured for: Blairex Laboratories, Inc. P.O. Box 2127 Columbus, IN 47202 USA

OTC - QUESTIONS SECTION

TelephoneQuestions or comments? Call TOLL FREE 1-800-252-4739
www.encare.net

Principal Display Panel - Carton Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 50486-221-18

with Nonoxynol-9

The Spermicide Doctors Recommend Most

Encare^®

Vaginal contraceptive inserts
for prevention of pregnancy

No Hormonal Side Effects

Easy To Use
Individually Wrapped
Convenient To Carry

18 INSERTS

Principal Display Panel - Carton Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 50486-221-12

with Nonoxynol-9

The Spermicide Doctors Recommend Most

Encare^®

Vaginal contraceptive inserts
for prevention of pregnancy

No Hormonal Side Effects

Easy To Use
Individually Wrapped
Convenient To Carry

12 INSERTS

Principal Display Panel - Carton Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Birth Control
Women Trust

NDC 50486-221-13

with Nonoxynol-9 The Spermicide
Doctors Recommend Most

Encare^®

Vaginal contraceptive
inserts for the
prevention of pregnancy

No
Hormonal
Side
Effects

Easy To Use
Individually Wrapped
Convenient To Carry

12 INSERTS

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
nonoxynol-9	ACTIVE INGREDIENT	48Q180SH9T	1
nonoxynol-9	ACTIVE MOIETY	48Q180SH9T	1
polyethylene glycol 1000	INACTIVE INGREDIENT	U076Q6Q621	1
polyethylene glycol 1450	INACTIVE INGREDIENT	OJ4Z5Z32L4	1
sodium bicarbonate	INACTIVE INGREDIENT	8MDF5V39QO	1
sodium citrate	INACTIVE INGREDIENT	1Q73Q2JULR	1
tartaric acid	INACTIVE INGREDIENT	W4888I119H	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

Encare
Nonoxynol-9
polyethylene glycol 1000
polyethylene glycol 1450
tartaric acid
sodium citrate
sodium bicarbonate

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
50486-221	50486-221-18, 50486-221-12, 50486-221-13

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
nonoxynol-9	48Q180SH9T	ACTIB
polyethylene glycol 1000	U076Q6Q621	IACT
polyethylene glycol 1450	OJ4Z5Z32L4	IACT
tartaric acid	W4888I119H	IACT
sodium citrate	1Q73Q2JULR	IACT
sodium bicarbonate	8MDF5V39QO	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 75 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
polyethylene glycol 1450	POLYETHYLENE GLYCOL 1450	OJ4Z5Z32L4	OINTMENT / TOPICAL		921 mg	Exact identifier — unii candidate 8 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS		3219 mg	Exact identifier — unii candidate 34 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	SOLUTION / ORAL		270 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	SYSTEM / TOPICAL		349 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	SUSPENSION / ORAL		40 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	CAPSULE, DELAYED RELEASE PELLETS / ORAL		4 mg	Exact identifier — unii candidate 34 equally ranked IID candidates
polyethylene glycol 1000	POLYETHYLENE GLYCOL 1000	U076Q6Q621	SOLUTION / ORAL	1000 mg/5ml		Exact identifier — unii candidate 9 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	TABLET, EFFERVESCENT / ORAL		57600 mg	Exact identifier — unii candidate 34 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	INJECTION / INTRAMUSCULAR		11 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
polyethylene glycol 1450	POLYETHYLENE GLYCOL 1450	OJ4Z5Z32L4	SUSPENSION / ORAL		4000 mg	Exact identifier — unii candidate 8 equally ranked IID candidates
polyethylene glycol 1000	POLYETHYLENE GLYCOL 1000	U076Q6Q621	AEROSOL, FOAM / TOPICAL	NA		Exact identifier — unii candidate 9 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	INJECTION / INTRATHECAL	0.05 mg		Exact identifier — unii candidate 34 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	GUM, CHEWING / BUCCAL		240 mg	Exact identifier — unii candidate 34 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	FILM, SOLUBLE / ORAL		2 mg	Exact identifier — unii candidate 34 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	1000 mg		Exact identifier — unii candidate 34 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		3059 mg	Exact identifier — unii candidate 34 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR		11 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	TABLET, FILM COATED / ORAL		30 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
polyethylene glycol 1450	POLYETHYLENE GLYCOL 1450	OJ4Z5Z32L4	TABLET, EXTENDED RELEASE / ORAL		9 mg	Exact identifier — unii candidate 8 equally ranked IID candidates
polyethylene glycol 1450	POLYETHYLENE GLYCOL 1450	OJ4Z5Z32L4	SUPPOSITORY / URETHRAL	9.75 mg		Exact identifier — unii candidate 8 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	TABLET, EXTENDED RELEASE / ORAL		96 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	POWDER, FOR SOLUTION / ORAL	1250 mg/100ml		Exact identifier — unii candidate 34 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	POWDER, FOR SOLUTION / ORAL		270 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	INJECTION / INTRAMUSCULAR		175 mg	Exact identifier — unii candidate 34 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	INJECTION / INTRAVENOUS	20 mg		Exact identifier — unii candidate 24 equally ranked IID candidates
polyethylene glycol 1450	POLYETHYLENE GLYCOL 1450	OJ4Z5Z32L4	CAPSULE, EXTENDED RELEASE / ORAL		91 mg	Exact identifier — unii candidate 8 equally ranked IID candidates
polyethylene glycol 1450	POLYETHYLENE GLYCOL 1450	OJ4Z5Z32L4	TABLET, FILM COATED / ORAL	0.13 mg		Exact identifier — unii candidate 8 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	TABLET / BUCCAL		42 mg	Exact identifier — unii candidate 34 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	TABLET, ORALLY DISINTEGRATING / ORAL		107 mg	Exact identifier — unii candidate 34 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	TABLET, EXTENDED RELEASE / ORAL		81 mg	Exact identifier — unii candidate 34 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	TABLET / SUBLINGUAL		6 mg	Exact identifier — unii candidate 34 equally ranked IID candidates
polyethylene glycol 1000	POLYETHYLENE GLYCOL 1000	U076Q6Q621	CREAM / TOPICAL	0.5 %w/w		Exact identifier — unii candidate 9 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	TABLET / SUBLINGUAL	NA		Exact identifier — unii candidate 24 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	INJECTION, SOLUTION / INTRAVENOUS		20 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
polyethylene glycol 1000	POLYETHYLENE GLYCOL 1000	U076Q6Q621	TABLET, FILM COATED / ORAL	1.52 mg		Exact identifier — unii candidate 9 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	SOLUTION / ORAL	ADJ PH		Exact identifier — unii candidate 34 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	INJECTION / SUBCUTANEOUS	ADJ PH		Exact identifier — unii candidate 34 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	INJECTION, SOLUTION / INTRAVENOUS		52 mg	Exact identifier — unii candidate 34 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	PELLET / ORAL		354 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	TABLET, ORALLY DISINTEGRATING / ORAL		45 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	TABLET / ORAL	1300 mg		Exact identifier — unii candidate 34 equally ranked IID candidates
polyethylene glycol 1450	POLYETHYLENE GLYCOL 1450	OJ4Z5Z32L4	SOLUTION / ORAL		6108 mg	Exact identifier — unii candidate 8 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	TABLET / ORAL		63 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	TABLET, FOR SUSPENSION / ORAL		28 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	SUPPOSITORY / RECTAL		43 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	INJECTION / INTRAVITREAL	0.18 %w/v		Exact identifier — unii candidate 34 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	20 mg		Exact identifier — unii candidate 24 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	SOLUTION / RESPIRATORY (INHALATION)	2 %w/w		Exact identifier — unii candidate 34 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	TABLET, COATED / ORAL	10 mg		Exact identifier — unii candidate 24 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	INJECTION / INTRAVENOUS	812 mg		Exact identifier — unii candidate 34 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	LOZENGE / ORAL		100 mg	Exact identifier — unii candidate 34 equally ranked IID candidates
polyethylene glycol 1000	POLYETHYLENE GLYCOL 1000	U076Q6Q621	GEL / TRANSDERMAL	0.5 %w/w		Exact identifier — unii candidate 9 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	SOLUTION, CONCENTRATE / INTRAVENOUS		20 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
polyethylene glycol 1000	POLYETHYLENE GLYCOL 1000	U076Q6Q621	CONCENTRATE / ORAL	100 mg/1ml		Exact identifier — unii candidate 9 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	TABLET, CHEWABLE / ORAL	140 mg		Exact identifier — unii candidate 34 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR	ADJ PH		Exact identifier — unii candidate 34 equally ranked IID candidates
sodium bicarbonate	SODIUM BICARBONATE	8MDF5V39QO	GRANULE, EFFERVESCENT / ORAL	267 mg		Exact identifier — unii candidate 34 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS	20 mg		Exact identifier — unii candidate 24 equally ranked IID candidates
tartaric acid	TARTARIC ACID	W4888I119H	CAPSULE / ORAL		400 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
polyethylene glycol 1000	POLYETHYLENE GLYCOL 1000	U076Q6Q621	GEL / TOPICAL		50 mg	Exact identifier — unii candidate 9 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
b17fbc07-781a-4916-9fc0-cdc0af924f84			a5d78ff6-31af-4c46-91b0-b7e5d40c1153	2013-09-03	Warnings	Exact identifier spl id: b17fbc07-781a-4916-9fc0-cdc0af924f84 spl set id: a5d78ff6-31af-4c46-91b0-b7e5d40c1153

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.